297 related articles for article (PubMed ID: 33582664)
21. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
Deftereos S; Giannopoulos G; Angelidis C; Alexopoulos N; Filippatos G; Papoutsidakis N; Sianos G; Goudevenos J; Alexopoulos D; Pyrgakis V; Cleman MW; Manolis AS; Tousoulis D; Lekakis J
Circulation; 2015 Oct; 132(15):1395-403. PubMed ID: 26265659
[TBL] [Abstract][Full Text] [Related]
22. Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI).
Madsen JM; Obling LER; Rytoft L; Folke F; Hassager C; Andersen LB; Vejlstrup N; Bang LE; Engstrøm T; Lønborg JT
Trials; 2023 Dec; 24(1):808. PubMed ID: 38102687
[TBL] [Abstract][Full Text] [Related]
23. A randomized multicenter trial to evaluate early invasive strategy for patients with acute ST-segment elevation myocardial infarction presenting 24-48 hours from symptom onset: Protocol of the RESCUE-MI study.
Gao W; Zhong X; Ma Y; Huang D; Wang R; Zhao S; Yang S; Qian J; Ge J
Am Heart J; 2022 Sep; 251():54-60. PubMed ID: 35525262
[TBL] [Abstract][Full Text] [Related]
24. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
Klingenberg R; Stähli BE; Heg D; Denegri A; Manka R; Kapos I; von Eckardstein A; Carballo D; Hamm CW; Vietheer J; Rolf A; Landmesser U; Mach F; Moccetti T; Jung C; Kelm M; Münzel T; Pedrazzini G; Räber L; Windecker S; Matter CM; Ruschitzka F; Lüscher TF
Am Heart J; 2022 May; 247():33-41. PubMed ID: 35092722
[TBL] [Abstract][Full Text] [Related]
25. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
MITOCARE Study Group
Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
[TBL] [Abstract][Full Text] [Related]
26. Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
Wang X; Guo R; Guo Y; Guo Q; Yan Y; Gong W; Zheng W; Wang H; Xu L; Ai H; Que B; Yan X; Ma X; Nie S
Am Heart J; 2023 Jun; 260():9-17. PubMed ID: 36822255
[TBL] [Abstract][Full Text] [Related]
27. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
[TBL] [Abstract][Full Text] [Related]
28. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
[TBL] [Abstract][Full Text] [Related]
29. Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial.
de Koning ML; van Dorp P; Assa S; Hartman MH; Voskuil M; Anthonio RL; Veen D; Pundziute-Do Prado G; Leiner T; van Goor H; van der Meer P; van Veldhuisen DJ; Nijveldt R; Lipsic E; van der Harst P
Am Heart J; 2022 Jan; 243():167-176. PubMed ID: 34534493
[TBL] [Abstract][Full Text] [Related]
30. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
31. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).
Siddiqi N; Bruce M; Neil CJ; Jagpal B; Maclennon G; Cotton SC; Papadopoulo SA; Bunce N; Lim P; Schwarz K; Singh S; Hildick-Smith D; Horowitz JD; Madhani M; Boon N; Kaski JC; Dawson D; Frenneaux MP
J Transl Med; 2013 May; 11():116. PubMed ID: 23648219
[TBL] [Abstract][Full Text] [Related]
32. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
[TBL] [Abstract][Full Text] [Related]
33. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
[TBL] [Abstract][Full Text] [Related]
34. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.
Nazir SA; McCann GP; Greenwood JP; Kunadian V; Khan JN; Mahmoud IZ; Blackman DJ; Been M; Abrams KR; Shipley L; Wilcox R; Adgey AA; Gershlick AH
Eur Heart J; 2016 Jun; 37(24):1910-9. PubMed ID: 27147610
[TBL] [Abstract][Full Text] [Related]
35. Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial.
Xia J; Wang X; Zhou J; Wang D; Pang Y; Xu X; Sang Z; Zhang Y; Zhang J; Wu S; Xiao Z; Hou L
Front Cardiovasc Med; 2022; 9():1009674. PubMed ID: 36211588
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
37. Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial.
Zhang X; Tian G; Shi Z; Sun Y; Hu J; Jiang Y; Zheng R; Chen S; Li C; Yang X; He T; Han S; Zhang C; Zhang L; Liu Y; Shang H;
Trials; 2020 Jan; 21(1):48. PubMed ID: 31915046
[TBL] [Abstract][Full Text] [Related]
38. BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials.
Shahim B; Redfors B; Chen S; Thiele H; Eitel I; Gkargkoulas F; Crowley A; Ben-Yehuda O; Maehara A; Stone GW
JACC Cardiovasc Interv; 2020 Apr; 13(8):965-972. PubMed ID: 32327093
[TBL] [Abstract][Full Text] [Related]
39. Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction - Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year.
Cuenin L; Lamoureux S; Schaaf M; Bochaton T; Monassier JP; Claeys MJ; Rioufol G; Finet G; Garcia-Dorado D; Angoulvant D; Elbaz M; Delarche N; Coste P; Metge M; Perret T; Motreff P; Bonnefoy-Cudraz E; Vanzetto G; Morel O; Boussaha I; Ovize M; Mewton N
Circ J; 2018 Apr; 82(5):1379-1386. PubMed ID: 28943533
[TBL] [Abstract][Full Text] [Related]
40. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset.
Desch S; Stiermaier T; de Waha S; Lurz P; Gutberlet M; Sandri M; Mangner N; Boudriot E; Woinke M; Erbs S; Schuler G; Fuernau G; Eitel I; Thiele H
JACC Cardiovasc Interv; 2016 Jan; 9(2):113-22. PubMed ID: 26793952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
